ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Angelini Pharma’s Ontozry available for patients in Scotland with drug-resistant epilepsy
February 09, 2022Angelini Pharma’s Ontozry available for patients in Scotland with drug-resistant epilepsy. -
Ontozry scores MHRA authorisation for focal-onset seizures
June 18, 2021The Medicines and Healthcare products Regulatory Agency (MHRA) has granted Arvelle Therapeutics’ Ontozry a marketing authorisation (MA) for the adjunctive treatment of focal-onset seizures, with or without secondary generalisation. -
EC approval for Ontozry
April 07, 2021Angelini Pharma has announced European Commission (EC) approval for anti-seizure drug Ontozry (cenobamate). -
Kesimpta and Vazkepa among latest CHMP recommendations
February 01, 2021The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended 13 new medicines for approval in its latest meeting.
Pharma Sources Insight January 2025
